SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-11
👔
Janux Therapeutics, Inc.
@JANX_InsiderForm 4 Filing: Campbell David Alan Exercises Options for $29,470 of $JANX
OPTION EXERCISE
⚡ MATERIALITY: 4/10
corporate issuer
Janux Therapeutics, Inc.
Ticker: $JANX
Transaction Value
$29,470
Price/Share: $4.21
transaction date
2026-07-08
Shares: 7,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Campbell David Alan, holds the title of President and CEO at Janux Therapeutics, Inc..
On 2026-07-08, the insider transacted 7,000 shares.The shares were transacted at a weighted average price of $4.21 per share, resulting in a total market-relevant value of $29,470.
Executive Summary Summary
Campbell David Alan (President and CEO) exercised options for $29K of $JANX
Post-Transaction Position: 388,582 shares
SEC Accession No: 0001864158-26-000004 (CIK: 1864158)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.